The science and commercial case - explained.
In-depth articles on Madagascar's biological heritage, the Nagoya Protocol, multi-omics data architecture, and why biological intelligence is the next frontier for pharmaceutical AI and agritech.
Audience-specific FAQs
Detailed Q&A for pharma, agritech, AI platforms, scientists, and compliance teams.
What Is the Nagoya Protocol and Why Does It Matter for Pharma and Agritech?
A plain-language guide to the Nagoya Protocol - what it requires, where pharma and agritech companies are exposed, and how compliant biodiversity data access works in practice. Covers EU ABS Regulation 511/2014, IRCC certificates, and the compliance gap most R&D teams haven't priced yet.
Read articleWhat Is Specimen-Level Multi-omics and Why Does It Matter?
What does it mean to have 8 layers of biological data from a single specimen? This article explains the multi-omics stack and why integrating them at specimen level produces intelligence that isolated datasets cannot.
Read articleIsoGentiX vs Public Databases - Why Provenance and Specimen-Level GUID Architecture Matter
Most biological databases aggregate data across specimens, losing the individual provenance chain. This article explains why specimen-level GUID architecture and blockchain anchoring produce something public databases cannot.
Read articleWhy AI Needs Novel Biological Training Data - and Why It Can't Just Use Public Databases
Foundation models trained on publicly available biological data are converging on the same knowledge ceiling. This article explains the training data saturation problem and why novel, provenance-clean biological data is the next critical input for life sciences AI.
Read articleWhy Madagascar? The Case for Endemic Vascular Plant Data
160 million years of island isolation produced a chemical space unlike anywhere on Earth. This article explains the biogeographic basis for Madagascar's extraordinary endemism - and why less than 0.08% of it has been genomically characterised.
Read articleMadagascar's Eastern Rainforest - The Alkaloid Frontier
The eastern rainforest strip holds the greatest concentration of endemic plant diversity on the island. Its Apocynaceae, Rubiaceae, and Loganiaceae species represent the primary alkaloid discovery target in the IsoGentiX programme.
Read articleThe Spiny Desert - Where Drought-Tolerance Genes Were Forged
Madagascar's spiny desert is the driest, hottest, most climatically extreme part of the island. The endemic flora it has produced - above all the Didiereaceae - has been solving extreme stress problems for millions of years using gene families absent from any crop genome.
Read articleMadagascar's Limestone Karst (Tsingy) - An Isolated Chemical Universe
Razor-edged stone formations have isolated plant populations in Madagascar's tsingy for millions of years - producing alkaloid and terpenoid chemistries with no known analogues anywhere on Earth.
Read articleMadagascar's Ultramafic Substrates - The Toxic Soil Specialists
Ultramafic soils are toxic to most plants - high in heavy metals, low in nutrients, with a chemistry that kills unadapted vegetation. The species that have evolved to survive on Madagascar's ultramafic outcrops have built entirely novel biochemical systems to do so.
Read articleSpecies of Interest - Full Index
Ten endemic Malagasy plant species profiled for pharmaceutical and agritech applications - one per ecoregion, each with documented chemistry and uncharacterised genes.
Catharanthus roseus - The $1.4 Billion Precedent
One plant from Madagascar produced two of oncology's most important chemotherapy drugs. That single species set the precedent for what biodiversity intelligence from this island is worth - and less than 0.08% of the endemic flora has been explored to equivalent depth.
Read articlePachypodium rosulatum - Stress Biology at the Extremes
The elephant foot plant survives bare rock, months of drought, and near-freezing nights simultaneously. The molecular toolkit it uses - encoded in a largely unsequenced genome - is a dual-interest target for both agritech and pharmaceutical discovery.
Read articleAlluaudia procera - The Drought Architecture Plant
The Didiereaceae evolved drought survival through entirely independent genetic pathways from cacti or African succulents. Alluaudia procera's genome - never fully sequenced - encodes novel water-stress solutions unavailable in any crop germplasm bank.
Read articleFive referenced articles and a full FAQ addressing the Nagoya Protocol, Madagascar's ABS framework, Free Prior and Informed Consent, benefit-sharing precedents, and in-country capacity building.
The Nagoya Protocol: From Convention to Compliance
Why the Nagoya Protocol exists, what PIC/MAT/IRCC require, and why compliance is a commercial asset. A plain-language guide to the international ABS framework and Madagascar's implementing legislation.
Read articleThe Rose Periwinkle: What History Demands We Do Differently
How one Madagascar plant generated vast pharmaceutical revenue - and why Madagascar received nothing. The historical case that shaped the entire international ABS regime.
Read articleFPIC in Practice: Community Consent as Operational Foundation
How IsoGentiX implements Free, Prior and Informed Consent across remote Madagascar communities - and why FPIC is operational infrastructure, not a compliance checkbox.
Read articleBenefit-Sharing That Works: Documented Precedents
Kani Tribe, INBio-Merck, Brazil's statutory floor, the Cali Fund - and the IsoGentiX approach. What the historical record shows about benefit-sharing models that deliver.
Read articleBuilding Scientific Capacity in Madagascar
Why monetary benefit-sharing alone is not enough - and how IsoGentiX builds permanent in-country scientific capability through the IsoGentiX Institute.
Read articleEthics & Governance FAQ
20 questions on the Nagoya Protocol, FPIC, benefit-sharing, and IsoGentiX's approach. All answers verifiable against cited primary sources.
Read FAQDigital Sequence Information & the Cali Fund
How a landmark global agreement is reshaping who benefits when biological data crosses borders - and why Madagascar is positioned to gain.
Read article - 12 minDSI & Cali Fund - FAQ
Plain answers to the questions we hear most often about DSI, the Cali Fund, and how IsoGentiX manages data traceability for Madagascar.
15 questionsWhy We Run on OVHcloud: Data Sovereignty, the CLOUD Act, and Why Infrastructure Is a Compliance Decision
The CLOUD Act allows US authorities to compel US cloud providers to hand over data stored anywhere in the world. This article explains why IsoGentiX uses EU sovereign cloud infrastructure - and what that means for your own compliance obligations as a licensee.
Read article - 9 minDownload any Knowledge Hub article as a branded PDF. We ask for your name and email before releasing the file so we can follow up if you have questions.
Frequently Asked QuestionsAudience-specific FAQs
Detailed answers for pharma R&D, agritech, AI platforms, academic scientists, and legal/compliance teams - covering data quality, licensing, Nagoya obligations, and methodology.
Want a structured briefing?
For a curated briefing tailored to your domain - pharmaceutical discovery, agritech, or AI training data - contact us directly. We can provide supporting materials, access to the data architecture overview, and an introduction to domain licensing terms.